Ugur Ozkerim
6PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Mar 14, 2026
Impact of Peri-Immunotherapy Antibiotic Exposure on Survival Outcomes in Metastatic Renal Cell Carcinoma: A Real-World IMDC Risk-Stratified Analysis.Sila Oksuz, Oguzcan Kinikoglu, Ugur Ozkerim
|Jan 28, 2026
Significance of CEA Dynamics and Systemic Inflammatory Markers in HER2-Positive Metastatic Colorectal Cancer Patients Undergoing First-Line Chemotherapy: A Real-World Cohort Study.Ugur Ozkerim, Oguzcan Kinikoglu, Sila Oksuz
|Jan 27, 2026
Development of a Machine Learning-Based Prognostic Model Using Systemic Inflammation Markers in Patients Receiving Nivolumab Immunotherapy: A Real-World Cohort Study.Ugur Ozkerim, Deniz Isik, Oguzcan Kinikoglu
|Jan 10, 2026
Association Between Time to PSA Nadir, Radiologic Progression, and PSA Progression in mHSPC Patients Treated with Abiraterone or Enzalutamide.Ugur Ozkerim, Oguzcan Kinikoglu, Deniz Isik
|May 27, 2024
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy.Sedat Yildirim, Akif Dogan, Goncagul Akdag
Pageof 1
Frequent Collaborators
6 joint publications
Hatice Odabas
6 joint publications
Oguzcan Kınıkoglu
6 joint publications
Nedim Turan
6 joint publications
Deniz Isik
5 joint publications
Tugba Basoglu
5 joint publications
Sila Oksuz
5 joint publications
Heves Surmeli
4 joint publications
Sedat Yildirim
4 joint publications
Yunus Emre Altintas
4 joint publications
Goncagul Akdag